Health MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial May 17, 2021
Health MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds February 11, 2021
Search
